From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.44
First Reported 1991
Last Reported 1995
Negated 0
Speculated 0
Reported most in Abstract
Documents 2
Total Number 2
Disease Relevance 2.10
Pain Relevance 0.91

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

extracellular space (Amy1a) carbohydrate metabolic process (Amy1a)
Amy1a (Rattus norvegicus)
Pain Link Frequency Relevance Heat
cva 3 98.96 Very High Very High Very High
fibrosis 2 96.92 Very High Very High Very High
Chronic pancreatitis 6 95.56 Very High Very High Very High
Clonidine 1 84.64 Quite High
antagonist 3 83.76 Quite High
ischemia 3 67.76 Quite High
Disease Link Frequency Relevance Heat
Weight Gain 2 99.92 Very High Very High Very High
Pressure And Volume Under Development 2 99.40 Very High Very High Very High
Hemorrhage 2 98.96 Very High Very High Very High
Fibrosis 2 96.92 Very High Very High Very High
Pancreatitis 10 95.56 Very High Very High Very High
Necrosis 2 93.68 High High
Fat Necrosis 1 93.00 High High
Frailty 2 91.68 High High
Cv Unclassified Under Development 3 67.76 Quite High
Injury 1 59.88 Quite High

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
While no difference between control and experiment was observed for serum alpha-amylase, weight gain, edema, and hemorrhage, persistent differences were evident for the parameters characteristic of chronic pancreatitis, most significantly for interstitial fibrosis, ductal changes, mononuclear infiltration, acinar necrosis, and atrophy.
Positive_regulation (observed) of serum alpha-amylase associated with fibrosis, necrosis, pressure and volume under development, frailty, cva, weight gain and chronic pancreatitis
1) Confidence 0.44 Published 1995 Journal Pancreas Section Abstract Doc Link 8532654 Disease Relevance 2.10 Pain Relevance 0.71
In conclusion, stimulation of both adrenoceptor subtypes is required for reduction of Ipeak, but stimulation of either alpha-1A or alpha-1B subtype is sufficient for reduction of Ilate.
Positive_regulation (stimulation) of alpha-1A
2) Confidence 0.19 Published 1991 Journal J. Pharmacol. Exp. Ther. Section Abstract Doc Link 1682485 Disease Relevance 0 Pain Relevance 0.20

General Comments

This test has worked.

Personal tools